TCL Archive In Brief: Board Subcommittee Meetings On Comprehensive Centers Postponed; FDA Committee Uncharted March 10, 1978
TCL Archive Phase III Trial Of PARP Inhibitor BSI-201 Opens For Triple-Negative Breast Cancer July 31, 2009
TCL Archive Facilities Survey: $2.5 Billion Will Be Required From 1986-1990, With NCI’s Share At $678 Million April 12, 1985
